The Business
Research Company published its Central Nervous System Drugs Global Market
Report 2020 which provides strategists, marketers and senior management with
the critical information they need to assess the global Central Nervous System
Drugs market. The report provides in-depth analysis of the impact of COVID-19
on the market, along with revised market numbers due to the effects of the
coronavirus.
The report
covers the Central Nervous System Drugs market’s segments-
1) By Type: Analgesics,
Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Other CNS Drugs
2) By
Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores,
Others
3) By Route
Of Administration: Oral, Parenteral, Others
4) By Drug
Classification: Branded Drugs, Generic Drugs
5) By Mode
Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
View Complete Report:
Central Nervous System Drugs Global Market Report 2020 is
the most comprehensive report available on this market and will help gain a
truly global perspective as it covers 60 geographies. The chapter on the impact
of COVID-19 gives valuable insights on supply chain disruptions, logistical
challenges, and other economic implications of the virus on the market. The
chapter also covers markets which have been positively affected by the
pandemic.
The global central nervous system drugs market is expected
to grow from $123.4 billion in 2019 to $136.7 billion in 2020 at a compound
annual growth rate (CAGR) of 10.8%. This growth is mainly due to the COVID-19
outbreak and the neuroinvasive nature of the virus. The CNS is more prone to
the viral infection. The virus affects the senses of smell and taste and
therefore it is important to curb the interaction between the viral protein and
the human receptor, and this factor is driving the demand for CNS drugs. The
market is then expected to recover and grow at a CAGR of 6% from 2021 and reach
$160.4 billion in 2023.
Pharmaceutical companies are partnering with technology
companies and incorporating wearables in clinical studies and for the research
and development of CNS disease treatments. These wearable devices make use of
sensors to detect early symptoms of Parkinson’s disease such as tremors,
slowness, and stiffness in patients. Researchers use this data to gain insights
about the disease and potential drug reactions, and thus reduce the time for
trials by 30% to 50%.
Few Points From Table Of Content
1. Executive
Summary
2. Report Structure
3. Central Nervous System Drugs Market Characteristics
4. Central Nervous System Drugs Market Product Analysis
5. Central Nervous System Drugs Market Supply Chain
……
20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
21. Market Background: Pharmaceutical Drugs Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer
2. Report Structure
3. Central Nervous System Drugs Market Characteristics
4. Central Nervous System Drugs Market Product Analysis
5. Central Nervous System Drugs Market Supply Chain
……
20. Key Mergers And Acquisitions In The Central Nervous System Drugs Market
21. Market Background: Pharmaceutical Drugs Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2141&type=smp
Few Points From List
Of Tables
Table 1: Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Central Nervous System Drugs Market, 2019,
By Region, Value ($ Billion)
Table 4: Global Central Nervous System Drugs Market,
2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
………
Table 122: Global Pharmaceutical Drugs Market, 2015-2019,
2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
Table 123: Global Central Nervous System Drugs Market In
2023- Growth Countries
Table 124: Global Central Nervous System Drugs Market In
2023- Growth Segments
Table 125: Global Central Nervous System Drugs Market In
2023- Growth Strategies
About The Business
Research Company:
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in the UK, the US and India and a
network of trained researchers in 52 countries globally.
Contact Information:
The Business Research
Company
Europe: +44 207 1930
708
Asia: +91 8897263534
Americas: +1 315 623
0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
